Market Overview

PTC Therapeutics (NASDAQ: PTCT)

46.12 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/25/20Raymond JamesInitiates Coverage OnOutperform63.0
8/10/20B of A SecuritiesMaintainsBuy58.0
8/10/20Credit SuisseMaintainsNeutral52.0
7/21/20SunTrust Robinson HumphreyMaintainsBuy86.0
5/01/20SunTrust Robinson HumphreyMaintainsBuy75.0
4/09/20CitigroupUpgradesBuy
4/08/20Cantor FitzgeraldReiteratesOverweight85.0
3/03/20Cantor FitzgeraldReiteratesOverweight86.0
2/20/20RBC CapitalDowngradesSector Perform60.0
2/20/20CitigroupDowngradesNeutral71.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter